"10.1371_journal.pone.0048548","plos one","2012-11-14T00:00:00Z","Beat Nyfeler; Yan Chen; Xiaoyan Li; Maria Pinzon-Ortiz; Zuncai Wang; Anupama Reddy; Elina Pradhan; Rita Das; Joseph Leh√°r; Robert Schlegel; Peter M Finan; Z Alexander Cao; Leon O Murphy; Alan Huang","Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America; Oncology Translational Medicine, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America","Conceived and designed the experiments: BN RS PMF ZAC LOM AH. Performed the experiments: YC XL MP-O ZW EP RD. Analyzed the data: BN AR JL ZAC AH. Wrote the paper: BN AR ZAC AH.","The authors have read the journals policy and have the following conflicts. Beat Nyfeler, Yan Chen, Xiaoyan Li, Maria Pinzon-Ortiz, Anupama Reddy, Joseph Lehar, Robert Schlegel, Peter M. Finan, Z. Alex Cao, Leon O. Murphy and Alan Huang are employees and/or share holders of Novartis Pharma AG. BEZ235 and RAD001 are either development or marketed products of Novartis Pharma AG. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2012","11","Beat Nyfeler","BN",14,TRUE,6,6,5,4,TRUE,TRUE,FALSE,0,NA,FALSE
